White Coat Hypertension: Clinical Trials

15 trials for White Coat Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 7 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Unknown 2
Phase 41Completed 1

Follow White Coat Hypertension: new trials by email Literature Review of White Coat Hypertension trials Research Report on White Coat Hypertension

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Hypertension
Not yet recruitingSunway University5002026-10-012026-08-25
Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings
Virtual Reality Exposure - White Coat Hypertension, Hypertension
Not applicableCompletedMayo Clinic792025-06-022025-11-05
Cardiovascular Risk in Children With Chronic Conditions Study
Kidney Transplant, Familial Hypercholesterolaemia
RecruitingSemmelweis University3002025-04-012025-08-08
Short Term Reproducibility of Office White-coat Effect
blood pressure measurement - White Coat Hypertension
Not applicableUnknownUniversity Hospital, Caen9222024-09-012024-07-26
Use of Automated Office Blood Pressure Monitoring
Blood pressure measurement device - Hypertension, Uncontrolled Hypertension
Not applicableCompletedUniversity of Alabama at Birmingham282021-03-052022-05-27
24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients
24-h-ABPM - NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension
UnknownUniversity Hospital of Cologne2002019-10-012020-09-10
Blood Pressure Control in ESH Excellence Centres
Blood Pressure, Lifestyle Risk Reduction
UnknownClinical Hospital Centre Zagreb30002018-10-012020-03-04
Home Blood Pressure (HBP)-Guided Management of Hypertension in Stage 3-4 CKD
Home Blood Pressure Monitoring - Hypertension, Chronic Kidney Diseases
Not applicableUnknownAristotle University Of Thessaloniki702018-06-022022-02-28
Implementing Hypertension Screening Guidelines in Primary Care
Multifaceted Implementation Strategy, Usual care - Hypertension,Essential, White Coat Hypertension
Not applicableCompletedColumbia University11862018-04-012025-06-13
Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes
Antihypertensiva, mainly Metyldopa - Pregnancy in Diabetics
CompletedCopenhagen University Hospital, Rigshospitalet5132016-02-012021-05-26
White-coat Hypertension in Childhood - Effects on Blood Pressure and Organ Damage
White Coat Hypertension
CompletedKarolinska Institutet562015-09-012024-09-19
Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)
Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence - Hypertension
Not applicableCompletedCentral Hospital, Nancy, France4032015-03-102023-06-22
Effect of Midazolam on White-coat Hypertensive Dental Patients
Midazolam, Normal Saline Solution (NSS) - Transient Hypertension
Not applicableCompletedOkayama University402010-10-012012-10-03
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
Lower body negative pressure (LBNP), Candesartan cilexetil - Hypertension, Obesity
Phase 4CompletedPD Dr. Grégoire Wuerzner782009-05-012017-05-24
Heart Rate Variability in White Coat Hypertension and Essential Hypertension
Monitoring of heart rate variability - Essential Hypertension, White Coat Hypertension
CompletedRegional Hospital Holstebro652006-09-11

Narrower conditions

Hypertension (11)  ·  Masked Hypertension (4)  ·  Essential Hypertension (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Obesity (2)  ·  Renal Insufficiency, Chronic (2)  ·  Anxiety Disorders (1)  ·  Aortic Coarctation (1)  ·  Aortic Valve Stenosis (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  HIV Infections (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hypertension Resistant to Conventional Therapy (1)

Broader conditions

Cardiovascular Diseases (15)  ·  Vascular Diseases (15)  ·  Hypertension (4)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Body Weight (2)  ·  Chronic Disease (2)  ·  Digestive System Diseases (2)  ·  Disease Attributes (2)  ·  Fatty Liver (2)  ·  Female Urogenital Diseases (2)  ·  Kidney Diseases (2)  ·  Liver Diseases (2)  ·  Male Urogenital Diseases (2)

Interventions

Blood Pressure Determination (1)  ·  Blood Pressure Monitoring, Ambulatory (1)  ·  Lower Body Negative Pressure (1)  ·  Midazolam (1)  ·  Saline Solution (1)  ·  Virtual Reality Exposure Therapy (1)  ·  candesartan cilexetil (1)

Sponsors

Aristotle University Of Thessaloniki (1)  ·  Central Hospital, Nancy, France (1)  ·  Clinical Hospital Centre Zagreb (1)  ·  Columbia University (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Karolinska Institutet (1)  ·  Mayo Clinic (1)  ·  Okayama University (1)  ·  PD Dr. GrĂ©goire Wuerzner (1)  ·  Regional Hospital Holstebro (1)  ·  Semmelweis University (1)  ·  Sunway University (1)  ·  University Hospital of Cologne (1)  ·  University Hospital, Caen (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (3)  ·  Denmark (2)  ·  Germany (2)  ·  Greece (2)  ·  Armenia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Erling B Pedersen, MD (1)  ·  Gregoire Wuerzner, MD (1)  ·  Ian Kronish, MD (1)  ·  Line B Madsen, MD (1)  ·  Lyle W Baker, MD (1)  ·  Michel Burnier, MD (1)  ·  Tamas Kiss, MD, PhD (1)  ·  Yook Chin Chia (1)  ·  Yoshihisa Watanabe, DDS (1)

Results publications

PMID 29876358, PMID 31628489, PMID 31781957, PMID 33073631, PMID 33368557, PMID 35766641, PMID 37747734, PMID 40838798, PMID 41085961, PMID 42723367

NIH funding

2014 (1)